News Releases

News Releases

Aug 6 2020
Avid Bioservices Selected By Iovance Biotherapeutics to Lead Process Development Through CGMP Manufacturing of Novel IL-2 Analog, IOV-3001
Jul 28 2020
Avid Bioservices and Argonaut Manufacturing Services Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Process Development, Drug Substance Manufacturing and Drug Product Parenteral Manufacturing
Jun 30 2020
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2020 and Recent Developments
Jun 23 2020
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2020 After Market Close on June 30, 2020
Jun 23 2020
Avid Bioservices Names Nicholas Green as President and Chief Executive Officer
Jun 3 2020
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
May 6 2020
Avid Bioservices and Aragen Bioscience Enter Agreement to Offer Biotechnology and Pharmaceutical Clients Integrated Solution for Cell Line and Process Development through Commercial Manufacturing
Apr 13 2020
Avid Bioservices Announces Appointment of Two Senior Directors of Business Development with Responsibility for North America, Europe and Asia
Mar 26 2020
Avid Bioservices Receives Five 2020 CMO Leadership Awards
Mar 10 2020
Avid Bioservices Reports Financial Results for Third Quarter Fiscal 2020 and Recent Developments